Specifically, the positive expression of SAMHD1 was significantly higher in DLBCL patients (positive rate = 60.0%, 60/100) than that in RHL tissues (positive rate = 35.0%, 7/20) (Figure 1C). This evidence concerns the gene SAMHD1 and diffuse large B-cell lymphoma.